Evidence map›Paper›PMID 21518865›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2011

Polycystin-1 regulates STAT activity by a dual mechanism.

Jeffrey J Talbot, Jonathan M Shillingford, Shivakumar Vasanth, Nicholas Doerr, Sambuddho Mukherjee, Mike T Kinter, Terry Watnick, Thomas Weimbs

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 134 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The GPCR properties of polycystin-1- A new paradigm.Frontiers in molecular biosciences · 2022
    Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Primary Cilia and Atherosclerosis.Frontiers in physiology · 2021
    Review
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Jeffrey J TalbotDepartment of Molecular, Cellular, and Developmental Biology and Neuroscience Research Institute, University of California, Santa Barbara, CA 93106-9610, USA.
Jonathan M Shillingford
Shivakumar Vasanth
Nicholas Doerr
Sambuddho Mukherjee
Mike T Kinter
Terry Watnick
Thomas Weimbs
Institut thématique Génétique, génomique et bioinformatique · FRJohns Hopkins Medicine · USOklahoma Medical Research Foundation · USUniversity of California, Santa Barbara · US

Funding

Research BaseP30DK090868 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI WATNICK, TERRY J · 2010 to 2019
$11.1M
STAT Regulation by Polycystin-1R01DK062338 · NIDDK · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI WEIMBS, THOMAS · 2002 to 2011
$2.6M
PKD1-Fibrillin Interactions and TFG-b Signaling PathwaysR01DK076017 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI WATNICK, TERRY J · 2006 to 2010
$1.5M
NIDDK NIH HHS DK076017NIDDK NIH HHS P30 DK090868NIDDK NIH HHS R01 DK062338NIDDK NIH HHS R01 DK076017
6 · The paper itself

Abstract

Mutations in polycystin-1 (PC1) lead to autosomal-dominant polycystic kidney disease (ADPKD), a leading cause of renal failure for which no treatment is available. PC1 is an integral membrane protein, which has been implicated in the regulation of multiple signaling pathways including the JAK/STAT pathway. Here we show that membrane-anchored PC1 activates STAT3 in a JAK2-dependent manner, leading to tyrosine phosphorylation and transcriptional activity. The C-terminal cytoplasmic tail of PC1 can undergo proteolytic cleavage and nuclear translocation. Tail-cleavage abolishes the ability of PC1 to directly activate STAT3 but the cleaved PC1 tail now coactivates STAT3 in a mechanism requiring STAT phosphorylation by cytokines or growth factors. This leads to an exaggerated cytokine response. Hence, PC1 can regulate STAT activity by a dual mechanism. In ADPKD kidneys PC1 tail fragments are overexpressed, including a unique ∼15-kDa fragment (P15). STAT3 is strongly activated in cyst-lining epithelial cells in human ADPKD, and orthologous and nonorthologous polycystic mouse models. STAT3 is also activated in developing, postnatal kidneys but inactivated in adult kidneys. These results indicate that STAT3 signaling is regulated by PC1 and is a driving factor for renal epithelial proliferation during normal renal development and during cyst growth.

Indexed as

AnimalsCell DeathCell LineCell ProliferationDisease Models, AnimalDogsHumansInterferon-gammaKidneyMiceMice, Inbred BALB CMice, Mutant StrainsMutationPhosphorylationPolycystic Kidney, Autosomal DominantRecombinant ProteinsInterferon-gammaRecombinant ProteinsSTAT1 Transcription FactorSTAT3 Transcription FactorSTAT Transcription FactorsTRPP Cation Channels

Identifiers

PMID21518865
PMCPMC3093515
OpenAlexW1981982858

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.